Works matching IS 03407004 AND DT 2012 AND VI 61 AND IP 10
Results: 25
In vivo imaging of immunotoxin treatment using Katushka-transfected A-431 cells in a murine xenograft tumour model.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1617, doi. 10.1007/s00262-012-1219-3
- By:
- Publication type:
- Article
TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1627, doi. 10.1007/s00262-012-1217-5
- By:
- Publication type:
- Article
Antigen-specificity of oligoclonal abnormal protein bands in multiple myeloma after allogeneic stem cell transplantation.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1639, doi. 10.1007/s00262-012-1220-x
- By:
- Publication type:
- Article
Enhanced activation of human dendritic cells by silencing SOCS1 and activating TLRs simultaneously.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1653, doi. 10.1007/s00262-012-1218-4
- By:
- Publication type:
- Article
Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1663, doi. 10.1007/s00262-012-1225-5
- By:
- Publication type:
- Article
Intratumoral electroporation of IL-12 cDNA eradicates established melanomas by Trp2-specific CD8+ CTLs in a perforin/granzyme-mediated and IFN-γ-dependent manner: application of Trp2 peptides.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1671, doi. 10.1007/s00262-012-1214-8
- By:
- Publication type:
- Article
Tumor-associated myeloid cells can be activated in vitro and in vivo to mediate antitumor effects.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1683, doi. 10.1007/s00262-012-1236-2
- By:
- Publication type:
- Article
Induction on differentiation and modulation of bone marrow progenitor of dendritic cell by methionine enkephalin (MENK).
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1699, doi. 10.1007/s00262-012-1221-9
- By:
- Publication type:
- Article
Inhibition of stromal CXCR4 impairs development of lung metastases.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1713, doi. 10.1007/s00262-012-1223-7
- By:
- Publication type:
- Article
Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1721, doi. 10.1007/s00262-012-1237-1
- By:
- Publication type:
- Article
Expression of CD40 and growth-inhibitory activity of CD40 agonist in ovarian carcinoma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1735, doi. 10.1007/s00262-011-1194-0
- By:
- Publication type:
- Article
Midkine upregulates MICA/B expression in human gastric cancer cells and decreases natural killer cell cytotoxicity.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1745, doi. 10.1007/s00262-012-1235-3
- By:
- Publication type:
- Article
Macrophage polarization induced by neuropeptide methionine enkephalin (MENK) promotes tumoricidal responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1755, doi. 10.1007/s00262-012-1240-6
- By:
- Publication type:
- Article
Hodgkin's lymphoma RNA-transfected dendritic cells induce cancer/testis antigen-specific immune responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1769, doi. 10.1007/s00262-012-1239-z
- By:
- Publication type:
- Article
Extended survival observed in adoptive activated T lymphocyte immunotherapy for advanced lung cancer: results of a multicenter historical cohort study.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1781, doi. 10.1007/s00262-012-1226-4
- By:
- Publication type:
- Article
Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1791, doi. 10.1007/s00262-012-1242-4
- By:
- Publication type:
- Article
CA215 and GnRH receptor as targets for cancer therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1805, doi. 10.1007/s00262-012-1230-8
- By:
- Publication type:
- Article
Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1819, doi. 10.1007/s00262-012-1229-1
- By:
- Publication type:
- Article
CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1833, doi. 10.1007/s00262-012-1245-1
- By:
- Publication type:
- Article
Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1849, doi. 10.1007/s00262-012-1231-7
- By:
- Publication type:
- Article
Second International Symposium on Cancer Biology (ISCB), November 14-16, 2011, at the National Institute of Immunology, New Delhi, India.
- Published in:
- 2012
- By:
- Publication type:
- Report
Endothelial cells in the eyes of an immunologist.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1609, doi. 10.1007/s00262-012-1335-0
- By:
- Publication type:
- Article
In memory of Professor Robert W. Baldwin: Editor-in-Chief of Cancer Immunology, Immunotherapy 1976-2003.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1883, doi. 10.1007/s00262-012-1349-7
- Publication type:
- Article
T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 × CD3 or CD19 × CD16.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1869, doi. 10.1007/s00262-012-1339-9
- By:
- Publication type:
- Article
DNA and adenovirus tumor vaccine expressing truncated survivin generates specific immune responses and anti-tumor effects in a murine melanoma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1857, doi. 10.1007/s00262-012-1296-3
- By:
- Publication type:
- Article